Development of Benzo[b]thiophene Linked-Oxadiazole Derivatives for Potential Antimicrobial and Anti-TB Targets: Evaluation of ADME-Tox and In-silico Docking
Jul 2026· Journal of Advanced Chemical Sciences· 0 citations· 43 references
TL;DR
The synthesis of new bis-oxadiazole-bearing benzo[b]thiophene derivatives are reported as well as assessments of their antimicrobial and antitubercular activity through both in vitro and in silico approaches, identifying promising oxadiazole-based inhibitors.
Abstract
The present work reports the synthesis of new bis-oxadiazole-bearing benzo[b]thiophene derivatives as well as assessments of their antimicrobial and antitubercular activity through both in vitro and in silico approaches. The novel benzo[b]thiophene-based oxadiazole derivatives (7a−7k) were synthesized via a three-step path involving the preparation of thioacetonitrile, followed by the conversion to acetimidamide, and finally cyclization with various functionalized benzoic acids. The structural elucidation of the prepared benzo[b]thiophene compounds was established by ¹H-NMR, ¹³C-NMR, and HRMS spectroscopic analysis. In vitro antimicrobial activity against Gram-(–ve), Gram(+ve) and fungal microorganisms and antitubercular effect on the H37Rv strain were assessed for each synthesized compound. It was revealed that compound 7f showed well-established antibacterial affinities on S. aureus and P. aeruginosa with zones of inhibition of 39.95±0.82 and 37.29±0.33 mm in comparison to the reference drug gemifloxacin (37.02±0.92 and 36.10±2.17 mm). Notably, compounds 7c and 7h displayed the highest antifungal activity among the tested compounds, with selectivity towards the C. albicans ZI values of 30.15±0.28 and 31.37±1.32 mm, with respects to CLZ (ZI = 29.36±1.15 mm). Among them, oxadiazole conjugates 7a (MIC = 5.80 μM), 7f (2.89 μM), and 7h (3.10 μM) showed potent anti-TB activity on the tested H37Rv compared to the conventional drug STM. Moreover, in silico molecular docking studies indicate that these conjugates strongly interrelate and bind with the C. albicans and M. tuberculosis active sites (PDB codes: 5FSA & 4FDN). Compound 7c showed the best docking score (−11.77 kcal/mol), followed by ligand 7f (−10.68 kcal/mol), with key H-bond interacting residues such as Gly⁷⁷(A), Ser⁷⁹(A), Arg⁷⁸(A), Thr¹⁴²(A), and Tyr⁴³⁵(A). Additionally, the synthesized compounds were screened for drug-likeness based on Lipinski’s rule of five and ADME-Tox parameters. Overall, the study identifies promising oxadiazole-based inhibitors and provides a valuable insight for further optimization and development of potential antimicrobial targets.
A series of thiazolo[5,4-b]pyridine–based sulfonamide derivatives was designed and synthesized using a cyanoacetyl sulfonamide intermediate to access various heterocyclic frameworks. Their antimicrobial activity was evaluated
in vitro
against
Staphylococcus aureus
,
Escherichia coli
, and
Candida albicans
using agar diffusion and minimum inhibitory concentration (MIC) determination. Several compounds exhibited potent antibacterial activity with MIC values ranging from 3.125 to 12.5 μg/mL, where compounds
10
,
16
, and
21
showed broad-spectrum activity comparable to or superior to reference drugs. Structure–activity relationship (SAR) analysis indicated that electron-withdrawing and aromatic substituents enhanced antimicrobial potency. Molecular docking studies against dihydrofolate reductase (DHFR, PDB ID: 2W9S) supported the experimental results, revealing favorable binding interactions and high affinity of the most active compounds. These findings suggest that thiazolo[5,4-b]pyridine–sulfonamide hybrids represent promising scaffolds for the development of new antimicrobial agents.
Noof A. Alenazi· Arabian Journal of Chemistry· 0 citations
A series of novel haloarene-decorated tetrahydropyridine derivatives B(1a–1f) were synthesized via a simple, environmentally benign one-pot multicomponent reaction employing ethanol as a green solvent and [Et₃NH][HSO₄] as a Brønsted acid ionic liquid catalyst. The reaction utilized methyl acetoacetate (1 mmol), substituted aromatic aldehydes (2 mmol), and substituted anilines (2 mmol) at 60 °C to afford the desired compounds. All compounds were evaluated for their in vitro antimicrobial activity against three fungal strains (Candida albicans, Aspergillus niger, and Aspergillus clavatus), two Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa), and two Gram-positive bacteria (Staphylococcus aureus and Streptococcus pyogenes), using the serial broth dilution method. Additionally, their antimalarial potential was assessed against chloroquine- and quinine-sensitive 3D7 and multidrug-resistant Dd2 strains of Plasmodium falciparum. Among the synthesized derivatives, compounds B1a, B1b, and B1b exhibited the most potent antimicrobial and antimalarial activities. Molecular docking studies revealed that compound B1f showed the highest binding affinity toward S. aureus nucleoside diphosphate kinase, with a predicted free binding energy of − 913 kcal/mol. Pharmacological profiling suggested favorable drug-like properties and non-toxic behavior. These findings highlight haloarene-decorated tetrahydropyridine derivatives as promising dual-action candidates with potential to combat both bacterial and malarial infections.
Bhavesh S. Hirani, Mohammad Murwih Alidmat, L. Hasoun et al.· Scientific Reports· 0 citations
A new series of non‐oxazolidinone derivatives
5a–d
and
6
was designed and synthesized as potential analogues of Linezolid. The aim of this work was to develop compounds with improved antibacterial activity, the ability to overcome bacterial resistance, and reduced toxicity. The synthesized compounds were evaluated for their in vitro antimicrobial activity against several pathogenic Gram‐positive and Gram‐negative bacterial strains, including multidrug‐resistant isolates (MRSA). In addition, a probability of resistance development assay was performed to assess their potential to induce bacterial resistance. The biological evaluation revealed that all synthesized derivatives exhibited lower antibacterial activity compared to Linezolid and gentamycin, highlighting the crucial role of the oxazolidinone ring in its antibacterial activity. Molecular docking studies were conducted to investigate the binding mode of the new compounds within the active site of the 50S ribosomal subunit. The docking results showed lacking structural superimposition with Linezolid within the binding pocket, and lacking several key interactions required for strong binding, which may explain their reduced antibacterial potency relative to the reference drug.
M. T. Nemr, Laila Ziko, Lobna Ghonaim et al.· ChemistrySelect· 0 citations
Objective: The rapid emergence of multi-drug resistant (MDR) bacterial pathogens has intensified the search for novel antimicrobial scaffolds. This study reports the design, synthesis, and biological evaluation of a new series of nitrone derivatives based on the Tinidazole scaffold. Methods: A library of compounds (M1–M3) was synthesized via the condensation of various aryl-substituted benzaldehydes with tinidazole-derived hydroxylamine intermediates. The molecular structures and stereochemical configurations of the synthesized hybrids were rigorously confirmed using spectral characterization techniques, including FT-IR, 1H NMR, 13C NMR, and Mass Spectrometry, which consistently indicated the formation of the stable (Z)-isomeric form. Results: The in vitro biological evaluation revealed that these nitrone derivatives possess potent broad-spectrum antibacterial activity against Gram-positive (Staphylococcus aureus) and Gram-negative (Klebsiella pneumoniae) clinical isolates. Notably, compounds M1 (4-F), M2 (H), and M3 (4-Br) exhibited exceptional zones of inhibition (ZOI) ranging from 41 to 46 mm at the highest concentrations, significantly outperforming the standard drug (ST), which reached a maximum ZOI of 22 mm. Furthermore, the compounds demonstrated significant antioxidant potential in the DPPH radical scavenging assay. Novelty: The Structure-Activity Relationship (SAR) analysis suggests that the electronic and lipophilic modulation of the aryl-substituted nitrone framework, particularly with halogenated substituents, plays a pivotal role in enhancing membrane permeability and bactericidal efficacy. These findings position tinidazole-based nitrones as highly promising candidates for the development of next-generation antimicrobial agents to combat resistant pathogens.
Prof. Mohammed Abdalla Hussein, Raheem Jameel Mohaisen· Journal of Medical Genetics...· 0 citations
The emergence of antimicrobial resistance needs the development of new chemotherapeutic scaffolds. Pyrazole derivatives are recognized for their broad biological activity; however, further structural innovation is required to enhance antimicrobial efficacy and safety. Thus, new pyrazole-based candidates were designed and synthesized using 3-(4-chlorophenyl)-1-phenylpyrazol-4-yl-2-cyanoacryloyl chloride as a versatile precursor. A series of mono- and bidentate nucleophile-derived compounds was prepared and evaluated for antimicrobial activity against Gram-positive and Gram-negative bacteria and Candida albicans. Several derivatives exhibited potent antibacterial and antifungal activity, particularly against Gram-positive strains, with minimum inhibitory concentrations comparable to standard drugs. Most compounds showed low cytotoxicity toward HepG2 cells, which was further reduced upon antioxidant co-treatment. Notably, vitamin C and N-acetylcysteine showed synergistic enhancement of antimicrobial and antibiofilm effects. Molecular docking studies against dihydropteroate synthase (DHPS, PDB: 5U0V) revealed favorable binding interactions, with the thiophene-based derivative 10 displaying ligand efficiency comparable to the co-crystallized ligand 7VJ. Overall, these findings highlight pyrazole-based scaffolds as promising antimicrobial candidates with favorable biological profiles, providing a strong basis for further structural optimization.
E. El‐Helw, Selwan Hamed, A. El-ziaty et al.· Scientific Reports· 0 citations